Basoglu, T; Sakin, A; Erol, C; Ozden, E; Cabuk, D; Cilbir, E; Ozyukseler, DT; Ayhan, M; Sendur, MA; Dogan, M; Oksuzoglu, B; Eryilmaz, MK; Er, O; Tasci, ES; Ozyurt, N; Dulgar, O; Ozen, M; Hacibekiroglu, I; Oner, I; Bekmez, ET; Yildirim, HC; Yalcin, S; Paydas, S; Yekeduz, E; Aksoy, A; Ozcelik, M; Oyman, A; Almuradova, E; Karabulut, B; Demir, N; Dincer, M; Ozdemir, N; Erdem, D; Ak, N; Inal, A; Salim, DK; Deniz, GI; Sakalar, T; Gulmez, A; Kacan, T; Ozdemir, O; Alan, O; Unal, C; Karakas, Y; Turhal, S; Yumuk, PF
Neoadjuvant chemotherapy (NACT) in gastroesophageal junction (GEJ) and gastric cancer (GC) was shown to improve survival in recent studies. We aimed to share our real-life experience of patients who received NACT to compare ...